Crinone 90 mg/1.125g (Progesterone GEL) 90 mg/1.125g

Crinone 90 mg/1.125g is a vaginal gel containing progesterone, used for hormonal support. This gel is designed for vaginal application and is available in a 15-applicator pack.

Strength

90 mg/1.125g

Pack Size

15 APPLICATOR in 1 CARTON (0023-6151-08) / 1.125 g in 1 APPLICATOR

Manufacturer / TM Owner

Allergan, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Crinone 90 mg/1.125g is a progesterone gel used for hormonal support in women. It is commonly prescribed to help maintain pregnancy in cases of progesterone deficiency. The gel is applied vaginally and is designed to deliver the hormone directly to the site of action. Crinone is often used in fertility treatments and to support early pregnancy.

Side Effects

When used as directed, Crinone 90 mg/1.125g may help support hormonal balance. Some users may experience local irritation or discomfort at the application site. It is important to follow the prescribed usage guidelines to minimize potential side effects.

Precautions & Warnings

Crinone 90 mg/1.125g should be used under medical supervision. Avoid using this gel if you are allergic to progesterone or any of its components. It is important to follow the prescribed dosage and application instructions to ensure safety and effectiveness.

Avoid Interactions

Crinone 90 mg/1.125g may interact with other medications, including hormonal therapies and certain antibiotics. Always inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be discussed with your healthcare provider.

Frequently Asked Questions

Crinone 90 mg/1.125g is used for hormonal support, often in fertility treatments and to support early pregnancy.

Crinone 90 mg/1.125g is applied vaginally using the provided applicators. Follow the instructions provided by your healthcare provider.

Common side effects may include local irritation or discomfort at the application site. Always consult your healthcare provider for personalized advice.

Crinone 90 mg/1.125g is often used to support early pregnancy. However, always consult your healthcare provider for specific advice.

Long-term use of Crinone 90 mg/1.125g should be monitored by a healthcare provider to ensure safety and effectiveness.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.